Abstract:Introduction: Oxidative stress plays an important role in ischemic stroke pathogenesis. L-glutamine (L-GLN) was shown to have antioxidant activity and was approved by the FDA in July 2017 for the treatment of sickle cell disease. In this study, we aim to investigate the effect of L-GLN in attenuating ischemic brain injury using a mouse middle cerebral artery occlusion (tMCAO) model. Methods: Ninety-minute tMCAO was used to induce a focal cerebral ischemic injury. Animals (n=135) were divided into four groups: (1) Sham, (2) Saline, (3) L-GLN, and (4) L-GLN plus HSP70 ATPase activity inhibitor Apoptozole (Az). Treatments were delivered intraperitoneally once daily for the first three days after ischemic surgery. Neurobehavioral tests were performed before tMCAO and at 1, 3, 7, and 14 days after tMCAO using the modified neurological severity score (mNSS), elevated body swing test (EBST), and rotarod test. Infarction volume was assessed by cresyl violet staining of brain sections. The expression levels of heat shock proteins and its signaling pathway related proteins were evaluated by Western Blot and real time-PCR. The level of oxidative stress was evaluated by malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GSH-PX) assays. Astrocyte and neuron cell cultures and oxygen glucose deprivation (OGD) model was used to further examine the molecular pathways involved in the protective effects by L-GLN. Results: L-GLN reduced brain infarct volume and promoted neurobehavioral recovery in mice suffering from ischemic injury. Such beneficial effect was abolished by the coadministration of AZ. L-GLN induced the up-regulation of HSP70, reduced oxidative stress level, and reduced the expression of IL-1beta and IL-6 in ischemic mice brain. In L-GLN group, SOD and GSH-PX activities are significantly increased compared to the Saline group. Nrf2 was upregulated in the L-GLN group while co-treatment with AZ abolished this upregulation. Cell culture experiments revealed that the conditioned media from astrocytes cultured with the presents of L-GLN attenuated the apoptosis of neurons after OGD. Conclusion: L-GLN attenuates ischemic brain injury in part through HSP70 related pathways and holds potential in post-stroke treatment.

Sustained blood glutamate scavenging enhances protection in ischemic stroke

Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke

Acamprosate Protects Rat Brain Against Middle-Cerebral-Artery-Occlusion-Induced Ischemic Injuries Through Anti-Oxidative Activities

Scavenging of Blood Glutamate for Enhancing Brain-to-blood Glutamate Efflux.

Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-stroke depression

Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke

Glutamate Antagonists in Therapy of Stroke

Abstract WP349: L-Glutamine Induces Heat Shock Protein 70 Expression & Attenuates Brain Ischemic Injury in Mice

Targeted Therapy of Ischemic Stroke Via Crossing the Blood-Brain Barrier Using Edaravone-Loaded Multiresponsive Microgels.

The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia.

Exogenous glutathione exerts a therapeutic effect in ischemic stroke rats by interacting with intrastriatal dopamine

γ-Glutamylcysteine ameliorates blood-brain barrier permeability and neutrophil extracellular traps formation after ischemic stroke by modulating Wnt/β-catenin signalling in mice

Blood-mediated scavenging of cerebrospinal fluid glutamate.

Glutamate-aspartate transporter 1 attenuates oxygen-glucose deprivation-induced injury by promoting glutamate metabolism in primary cortical neurons

L-glutamine Protects Mouse Brain from Ischemic Injury Via Up-Regulating Heat Shock Protein 70

An Evaluation of Erythrocytes as Plasma Glutamate Scavengers for Enhanced Brain-to-Blood Glutamate Efflux

Amburana cearensis seed extract stimulates astrocyte glutamate homeostatic mechanisms in hippocampal brain slices and protects oligodendrocytes against ischemia

Inhibition of Vesicular Glutamate Transporters (VGLUTs) with Chicago Sky Blue 6B Before Focal Cerebral Ischemia Offers Neuroprotection

Targeted Alleviation of Ischemic Stroke Reperfusion Via Atorvastatin-Ferritin Gd-layered Double Hydroxide

Activation of Glutamate Transporter-1 (GLT-1) Confers Sex-Dependent Neuroprotection in Brain Ischemia

Neuroprotection By Combined Administration With Maslinic Acid, A Natural Product From Olea Europaea, And Mk-801 In The Cerebral Ischemia Model